John R. Warren
@Farallon Capital Management Llc
Latest period2024 - Q3ReportedManaged Assets$20.437BTotal holdings153
Assets growth rate-3.56%Assets growth rate (2-Q avg)-3.73%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Farallon Capital Management Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 153 positions.
Assets under management
The assets under management (AUM) of Farallon Capital Management Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 20.437B in assets, with a quarterly growth rate of -3.56% and a 2-quarter average growth rate of -3.73%. The portfolio is managed by John R. Warren, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
LNTHLantheus Hldgs Inc
| 1.59% | $324.336M 2.955M shares@ $109.75 avg price | Increased 29.66% |
SRPTSarepta Therapeutics Inc
| 1.58% | $322.216M 2.58M shares@ $124.89 avg price | Increased 6.25% |
ABNBAirbnb Inc
| 1.48% | $300.692M 2.371M shares@ $126.81 avg price | Increased 39.41% |
PTGXProtagonist Therapeutics Inc
| 1.3% | $263.745M 5.861M shares@ $45.0 avg price | Increased 0.35% |
AGIOAgios Pharmaceuticals Inc
| 1.24% | $251.512M 5.661M shares@ $44.43 avg price | Increased 0.12% |
MAMastercard Incorporated
| 1.23% | $250.194M 506,671 shares@ $493.81 avg price | Increased 9.49% |
MRNAModerna Inc
| 1.15% | $233.905M↓ Put 3.5M shares@ $66.83 avg price | Increased 169.24% |
BEAMBeam Therapeutics Inc
| 0.99% | $201.099M 8.208M shares@ $24.51 avg price | Increased 3.73% |
EDUNew Oriental Ed & Technology
| 0.95% | $192.148M 2.534M shares@ $75.84 avg price | Increased 72.41% |
BHVNBiohaven Ltd
| 0.9% | $182.02M 3.643M shares@ $49.97 avg price | Increased 62.04% |